{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T20:53:31Z","timestamp":1786136011828,"version":"build-2736575974"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"32","license":[{"start":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:00:00Z","timestamp":1786060800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,8,7]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      The precise association between the atherogenic index of plasma (AIP) and its derived anthropometric indicators and the future risk of liver diseases and alcoholic liver disease among Chinese middle-aged and elderly adults remains unclear. The study population was derived from the China Health and Retirement Longitudinal Study. Incident liver disease cases were identified based on self-reported questionnaire information. The AIP and its related indicators were calculated using laboratory results from participants blood samples. We employed Cox regression to assess the associations between cumulative and categorical AIP, as well as related indicators, and the occurrence of liver disease. Additionally, restricted cubic splines were used to examine potential nonlinear relationships between cumulative AIP and liver disease risk. The mean age of the 9027 participants was 61.20\u2005\u00b1\u20059.54 years, and 438 (4.85%) subjects developed liver disease during a median follow-up duration of 7 years. After full adjustment for confounders, each 1-standard deviation increase in AIP was associated with a 15% higher risk of liver disease (HR\u2005=\u20051.15; 95% confidence intervals: 1.02\u20131.30;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.020). Similarly, higher levels of AIP-BMI, AIP-WC, and AIP-BRI were associated with increased liver disease risk. restricted cubic splines analyses visually confirmed a positive dose-response relationship between AIP and its related indicators and liver disease risk, with no significant nonlinear trends. Additionally, subgroup analyses and sensitivity analyses confirmed that higher levels of AIP are associated with a higher risk of liver disease. In this national cohort, higher AIP was associated with an increased risk of self-reported liver disease. Long-term monitoring of AIP may help identify individuals for further hepatic assessment. However, confounding from unmeasured factors including viral hepatitis cannot be ruled out.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000050030","type":"journal-article","created":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T18:01:49Z","timestamp":1786125709000},"page":"e50030","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Association of the atherogenic index of plasma and derived indicators with future risk of liver diseases and alcoholic liver disease among Chinese middle-aged and elderly adults: A nationwide cohort study"],"prefix":"10.1097","volume":"105","author":[{"given":"Meng","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-2338-1401","authenticated-orcid":false,"given":"Changhong","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tie-Jun","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"Suppl","key":"R1-20260807","doi-asserted-by":"crossref","first-page":"S302","DOI":"10.3350\/cmh.2022.0329","article-title":"Non-alcoholic fatty liver disease: the pathologist\u2019s perspective.","volume":"29","author":"Leow","year":"2023","journal-title":"Clin Mol Hepatol"},{"key":"R2-20260807","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1186\/s12876-025-04264-5","article-title":"Global burden of cirrhosis and other chronic liver diseases caused by specific etiologies from 1990 to 2021.","volume":"25","author":"Zhang","year":"2025","journal-title":"BMC Gastroenterol"},{"key":"R3-20260807","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1002\/hep.27406","article-title":"The global burden of liver disease: the major impact of China.","volume":"60","author":"Wang","year":"2014","journal-title":"Hepatology"},{"key":"R4-20260807","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3390\/nu10010009","article-title":"Nutrition and liver disease.","volume":"10","author":"Mandato","year":"2017","journal-title":"Nutrients"},{"key":"R5-20260807","doi-asserted-by":"crossref","first-page":"100873","DOI":"10.1016\/j.aohep.2022.100873","article-title":"Diagnostic accuracy of blood biomarkers and non-invasive scores for the diagnosis of MAFLD and NASH: systematic review and meta-analysis.","volume":"28","author":"Contreras","year":"2023","journal-title":"Ann Hepatol"},{"key":"R6-20260807","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/s42255-023-00775-1","article-title":"A proteo-transcriptomic map of non-alcoholic fatty liver disease signatures.","volume":"5","author":"Govaere","year":"2023","journal-title":"Nat Metab"},{"key":"R7-20260807","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/s41575-021-00502-9","article-title":"Metabolomics and lipidomics in MAFLD: biomarkers and non-invasive diagnostic tests.","volume":"18","author":"Masoodi","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R8-20260807","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/S2468-1253(23)00066-3","article-title":"Non-invasive diagnosis and monitoring of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.","volume":"8","author":"Tincopa","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R9-20260807","doi-asserted-by":"crossref","first-page":"4212","DOI":"10.3390\/nu16234212","article-title":"Genetic risk, BMI status, BMI change patterns, and the risk of steatotic liver disease and liver enzyme elevation in Chinese adults.","volume":"16","author":"Yang","year":"2024","journal-title":"Nutrients"},{"key":"R10-20260807","doi-asserted-by":"crossref","first-page":"6997280","DOI":"10.1155\/2024\/6997280","article-title":"Association between BMI change, transaminases, and other metabolic parameters in children with nonalcoholic fatty liver disease.","volume":"2024","author":"Flores Lopez","year":"2024","journal-title":"J Obes"},{"key":"R11-20260807","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.3390\/biomedicines10092101","article-title":"Atherogenic index of plasma in non-alcoholic fatty liver disease: systematic review and meta-analysis.","volume":"10","author":"Ismaiel","year":"2022","journal-title":"Biomedicines"},{"key":"R12-20260807","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s12933-023-01886-5","article-title":"Nonlinear association of atherogenic index of plasma with insulin resistance and type 2 diabetes: a cross-sectional study.","volume":"22","author":"Yin","year":"2023","journal-title":"Cardiovasc Diabetol"},{"key":"R13-20260807","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12933-025-02589-9","article-title":"Association between atherogenic index of plasma and future risk of cardiovascular disease in individuals with cardiovascular-kidney-metabolic syndrome stages 0-3: a nationwide prospective cohort study.","volume":"24","author":"Zheng","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"R14-20260807","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1186\/s12944-024-02325-4","article-title":"Association of diabetic retinopathy with plasma atherosclerotic index, visceral obesity index, and lipid accumulation products: NHANES 2005-2008.","volume":"23","author":"Wei","year":"2024","journal-title":"Lipids Health Dis"},{"key":"R15-20260807","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/ije\/dys203","article-title":"Cohort profile: the China health and retirement longitudinal study (CHARLS).","volume":"43","author":"Zhao","year":"2014","journal-title":"Int J Epidemiol"},{"key":"R16-20260807","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12933-023-01740-8","article-title":"Sex-specific differences in the effect of the atherogenic index of plasma on prediabetes and diabetes in the NHANES 2011-2018 population.","volume":"22","author":"Shi","year":"2023","journal-title":"Cardiovasc Diabetol"},{"key":"R17-20260807","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s40001-022-00731-x","article-title":"Atherogenic index of plasma is an independent predictor of metabolic-associated fatty liver disease in patients with type 2 diabetes.","volume":"27","author":"Samimi","year":"2022","journal-title":"Eur J Med Res"},{"key":"R18-20260807","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.metabol.2018.11.014","article-title":"Obesity and nonalcoholic fatty liver disease: from pathophysiology to therapeutics.","volume":"92","author":"Polyzos","year":"2019","journal-title":"Metabolism"},{"key":"R19-20260807","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.freeradbiomed.2020.02.025","article-title":"Role of oxidative stress in the pathogenesis of nonalcoholic fatty liver disease.","volume":"152","author":"Chen","year":"2020","journal-title":"Free Radic Biol Med"},{"key":"R20-20260807","doi-asserted-by":"crossref","first-page":"15695","DOI":"10.1038\/s41598-025-01003-4","article-title":"Association of cardiometabolic markers with hepatic steatosis and liver fibrosis in population without obesity and diabetes.","volume":"15","author":"Fan","year":"2025","journal-title":"Sci Rep"},{"key":"R21-20260807","doi-asserted-by":"crossref","first-page":"159065","DOI":"10.1016\/j.bbalip.2021.159065","article-title":"HDL and reverse cholesterol transport in humans and animals: lessons from pre-clinical models and clinical studies.","volume":"1867","author":"Zanotti","year":"2022","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"R22-20260807","doi-asserted-by":"crossref","first-page":"101092","DOI":"10.1016\/j.molmet.2020.101092","article-title":"Dysregulated lipid metabolism links MAFLD to cardiovascular disease.","volume":"42","author":"Deprince","year":"2020","journal-title":"Mol Metab"},{"key":"R23-20260807","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41598-024-84649-w","article-title":"Elevated GGT to HDL ratio as a marker for the risk of MAFLD and liver fibrosis.","volume":"15","author":"Xuan","year":"2025","journal-title":"Sci Rep"},{"key":"R24-20260807","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.jhep.2017.01.022","article-title":"NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice.","volume":"66","author":"Mridha","year":"2017","journal-title":"J Hepatol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000050030","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T20:02:30Z","timestamp":1786132950000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000050030"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,7]]},"references-count":24,"journal-issue":{"issue":"32","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000050030","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,7]]},"assertion":[{"value":"2025-11-06","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-19","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}